======= IFITM2 =======
== Gene Information ==
* **Official Symbol**: IFITM2
* **Official Name**: interferon induced transmembrane protein 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10581|10581]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q01629|Q01629]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=IFITM2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20IFITM2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/605578|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: IFN-induced antiviral protein which inhibits the entry of viruses to the host cell cytoplasm, permitting endocytosis, but preventing subsequent viral fusion and release of viral contents into the cytosol. Active against multiple viruses, including influenza A virus, SARS coronavirus (SARS-CoV), Marburg virus (MARV), Ebola virus (EBOV), Dengue virus (DNV), West Nile virus (WNV), human immunodeficiency virus type 1 (HIV-1) and vesicular stomatitis virus (VSV). Can inhibit: influenza virus hemagglutinin protein-mediated viral entry, MARV and EBOV GP1,2-mediated viral entry, SARS-CoV S protein-mediated viral entry and VSV G protein- mediated viral entry. Induces cell cycle arrest and mediates apoptosis by caspase activation and in p53-independent manner. {ECO:0000269|PubMed:19544527, ECO:0000269|PubMed:20064371, ECO:0000269|PubMed:20534863, ECO:0000269|PubMed:20943977, ECO:0000269|PubMed:21177806, ECO:0000269|PubMed:21253575, ECO:0000269|PubMed:22479637}.
|CD225|
|negative regulation of viral entry into host cell|
|response to interferon-alpha|
|response to interferon-beta|
|regulation of viral entry into host cell|
|negative regulation of viral genome replication|
|cellular response to type I interferon|
|type I interferon signaling pathway|
|response to type I interferon|
|negative regulation of viral life cycle|
|regulation of viral genome replication|
|negative regulation of viral process|
|regulation of viral life cycle|
|response to interferon-gamma|
|defense response to virus|
|regulation of viral process|
|negative regulation of multi-organism process|
|regulation of symbiosis, encompassing mutualism through parasitism|
|response to virus|
|protein-containing complex|
|cytokine-mediated signaling pathway|
|innate immune response|
|regulation of multi-organism process|
|defense response to other organism|
|cellular response to cytokine stimulus|
|immune effector process|
|response to cytokine|
|response to other organism|
|response to external biotic stimulus|
|response to biotic stimulus|
|defense response|
|immune response|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp180|Dynasore 10μM R04 exp180]]|1.86|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 85/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|5/28|
|blood|4/28|
|bone|1/26|
|breast|4/33|
|central nervous system|7/56|
|cervix|2/4|
|colorectal|4/17|
|esophagus|1/13|
|fibroblast|0/1|
|gastric|3/16|
|kidney|0/21|
|liver|2/20|
|lung|7/75|
|lymphocyte|3/16|
|ovary|2/26|
|pancreas|0/24|
|peripheral nervous system|2/16|
|plasma cell|5/15|
|prostate|0/1|
|skin|3/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|3/22|
|urinary tract|5/29|
|uterus|1/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 14294
* **Expression level (log2 read counts)**: 6.46
{{:chemogenomics:nalm6 dist.png?nolink |}}